Insmed's facilities include: 50,000 sq. ft. state-of-the-art Biologics Manufacturing Facility and Process and Analytical Laboratory in Boulder, CO
The company's state-of-the-art manufacturing facility has already been FDA-inspected and approved for the commercial production of IPLEX™ for the Primary IGFD indication. Located in the biotech hub of Boulder, Colorado, the facility is a technological asset for Insmed. Given its advanced protein manufacturing capability, combined with a skilled work force, the company is positioned to leverage its process expertise in any number of new ventures, either through acquisitions or partnering activities. The facility's potential for expanded capacity allows Insmed to be poised for production of follow on biologics.
